CVS Health Corp (CVS · NYSE)
CVS · MARKET VIEW
Market view · as of Sep 21, 2026
Revenue (TTM)
$412.64B
+7.1% YoY
Gross margin
13.6%
EPS (latest q)
$2.58
vs $1.87 est · beat
52-wk position
48.4%
-19.2% vs 52w high · -5.1% 1mo
Price (last ~year)
CVS Health reported Q2 (June 30, 2026) revenue of $106.10B, up 7.1% YoY, with net income of $3.00B and EPS of $2.58 versus $1.87 estimated — its fourth consecutive earnings beat. The quarter marks a sharp recovery from the September 2025 loss of $3.98B, though margins remain thin at 1.2% net and leverage sits at 4.6x debt/EBITDA against $76.31B in total debt. Despite the fundamentals, the stock has fallen 12.2% over three months to $88.84, trading 19.2% below its 52-week high on 3.3x average volume. Wall Street Zen upgraded shares to "strong-buy" on September 20, while the analyst target of $116.28 implies meaningful upside to the last close.
Valuation
- Market cap
- $113.62B
- P/E
- 23.44
- PEG
- 0.208
- P/B
- 1.426
- P/S
- 0.275
- EV/EBITDA
- 13.12
- Beta
- 0.58
- Analyst target
- $116.28
Quality & returns
- Gross margin
- 13.6%
- Operating margin
- 3.9%
- Profit margin
- 1.2%
- ROE
- 6.2%
- ROA
- 3.0%
Price movement
- Last
- $88.84
- 1-month
- -5.1%
- 3-month
- -12.2%
- RSI (14)
- 36
- vs SMA200
- +2.8%
- 52-wk position
- 48.4% -19.2% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $106.10B | $4.70B | $3.00B | $5.86B |
| 2026-03-31 | $100.43B | $4.68B | $2.94B | $5.83B |
| 2025-12-31 | $105.69B | $2.11B | $2.94B | $3.29B |
| 2025-09-30 | $102.87B | $-3.21B | $-3.98B | $-1.56B |
Recent news
- Bullish CVS Health (NYSE:CVS) Raised to "Strong-Buy" at Wall Street Zen · 2026-09-20
- Somewhat-Bullish Cardinal Health Targets 13%-15% EPS Growth as Specialty Momentum Builds · 2026-09-19
- Somewhat-Bullish Guardant Health’s Shield Blood Test Covered by Carelon Health Services for Colorectal Cancer Screening · 2026-09-19
- Somewhat-Bullish Former J&J Unit Beats Claims Its Sunscreen Caused Cancer · 2026-09-18
- Bullish CVS Health is making a difference in local communities, one classroom at a time · 2026-09-18
- Bullish Health Insurance Providers Stocks Q2 Earnings Review: CVS Health (NYSE:CVS) Shines · 2026-09-18
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)